JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist
  • 894
  • +107+13.60%
20min DelayMarket Closed May 1 15:30 JST
355.72BMarket Cap-1.13P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sumitomo Pharma Q4 2025 Estimates Date

Currency：JPYMay 13, 2025

Estimate YoY
Revenue
87.91B
+10.54%
EPS
-12.32
+97.52%
Analyst Rating
Hold

Apr 22, 2025

Sumitomo Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 82.197B--
May 13, 20252025/Q4-- / 87.911B--
Jan 31, 20252025/Q3112.434B / 90.567B--
Oct 30, 20242025/Q290.074B / 85.908B--
Jul 31, 20242025/Q190.675B / 82.622B--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 82.197B--
May 13, 20252025/Q4-- / 87.911B--
Jan 31, 20252025/Q3112.434B / 90.567B--
Oct 30, 20242025/Q290.074B / 85.908B--
Jul 31, 20242025/Q190.675B / 82.622B--

Unlock Free Earnings Estimates

Sumitomo Pharma Earnings Reports

  • Sumitomo Pharma: Revised Extraordinary Report

    Apr 28 04:06 ET

  • Sumitomo Pharma: Interim report.

    Apr 28 04:03 ET

  • Sumitomo Pharma: Notice regarding revisions to earnings forecasts and recording of transfer gains

    Apr 28 04:00 ET

  • Sumitomo Pharma: Extraordinary Report

    Apr 3 03:39 ET

    • Read more

    Market Insights

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    Metaplanet
    3350
    394
    Murata Manufacturing
    6981
    1930.5
    Mitsui O.S.K. Lines
    9104
    4563.0
    4
    Alt
    260A
    113
    5
    Mitsubishi UFJ Financial Group
    8306
    1782.0
    Log In for the Full List
    Unlock Now